CTOs on the Move

StriVectin

www.strivectin.com

 
Our mission is simple. Deliver the most high-performance skincare and haircare solutions powered by the latest clinical advances to transform the look of your skin and hair. At the center of every formula is patented, proprietary NIA-114 technology that supercharges StriVectin`s clinically proven, award winning products.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.strivectin.com
  • 601 West 26th Street Suite 1505
    New York, NY USA 10001
  • Phone: 800.430.0227

Executives

Name Title Contact Details

Similar Companies

Occulogix

Occulogix, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Occulogix, Inc. is based in Elliot Lake, ON. You can find more information on Occulogix, Inc. at www.occulogix.com

AirWare Labs

A globally patented adhesive-free nasal insert. Take advantage of your nasal system for optimal health. Drug-free, latex-free. All natural, instant relief.

Current Health

Current Health offers an enterprise care-at-home platform to enable healthcare organizations to deliver high-quality, patient-centric care at a lower cost. The company integrates patient-reported data with data from biosensors – including their own continuous monitoring wearable device – to provide healthcare organizations with actionable, real-time insights into the patient’s condition. Leveraging clinical algorithms that can be tailored to the individual patient, Current Health identifies when a patient needs clinical attention, allowing organizations to manage patient care remotely or coordinate in-home care via our integrated service partners. The Current Health platform brings together telehealth capabilities, patient engagement tools, and in-home connectivity to provide a single solution to manage all care in the home.

COREBIO GROUP

COREBIO GROUP is a Belmont, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tocagen

Tocagen is a clinical stage, biopharmaceutical company pursuing the discovery, development and commercialization of gene therapy products for the treatment of cancer.